Found: 2
Select item for more details and to access through your institution.
Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 4, p. 596, doi. 10.1007/s12282-023-01451-8
- By:
- Publication type:
- Article